CINECA IRIS Institutional Research Information System

BIOLATTI, Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3377
EU - Europa 2235
AS - Asia 810
AF - Africa 54
SA - Sud America 40
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6550
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3318
IT - Italia 894
CN - Cina 414
IE - Irlanda 313
SE - Svezia 230
DE - Germania 135
AT - Austria 104
GB - Regno Unito 103
FR - Francia 97
VN - Vietnam 93
UA - Ucraina 90
JP - Giappone 78
IN - India 59
FI - Finlandia 47
CA - Canada 41
PL - Polonia 41
KR - Corea 37
BE - Belgio 35
AU - Australia 29
SN - Senegal 29
HK - Hong Kong 27
GR - Grecia 26
NL - Olanda 25
TW - Taiwan 19
ES - Italia 16
TR - Turchia 15
DK - Danimarca 14
IR - Iran 14
MX - Messico 14
IL - Israele 12
NO - Norvegia 11
BR - Brasile 10
IQ - Iraq 10
SI - Slovenia 10
RU - Federazione Russa 9
ZA - Sudafrica 9
CO - Colombia 8
PH - Filippine 8
RO - Romania 8
PE - Perù 7
PK - Pakistan 7
SG - Singapore 7
AR - Argentina 5
CH - Svizzera 5
HR - Croazia 5
TN - Tunisia 5
CL - Cile 4
NZ - Nuova Zelanda 4
PR - Porto Rico 4
SK - Slovacchia (Repubblica Slovacca) 4
LU - Lussemburgo 3
MA - Marocco 3
NG - Nigeria 3
ZM - Zambia 3
BD - Bangladesh 2
BG - Bulgaria 2
BY - Bielorussia 2
EC - Ecuador 2
GY - Guiana 2
ID - Indonesia 2
MY - Malesia 2
RS - Serbia 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
EG - Egitto 1
EU - Europa 1
IS - Islanda 1
JO - Giordania 1
LB - Libano 1
MU - Mauritius 1
NP - Nepal 1
PT - Portogallo 1
UY - Uruguay 1
YE - Yemen 1
Totale 6550
Salva come PNG Salva come JPEG
Città #
Chandler 849
Dublin 313
Torino 205
Fairfield 180
Beijing 170
Ann Arbor 129
Houston 120
Woodbridge 116
Sovicille 115
Redwood City 100
Vienna 97
Jacksonville 91
Nyköping 91
Wilmington 85
Princeton 79
Cambridge 78
Ashburn 77
Medford 70
Pisa 69
Seattle 68
Dong Ket 65
Dearborn 62
Villeurbanne 59
Guangzhou 46
Boston 43
Fremont 41
Warsaw 36
Rome 35
Norwalk 26
Hebei 24
Milan 23
Turin 23
Maddaloni 22
San Diego 21
Brussels 20
Taipei 19
Boardman 14
Seoul 14
Thebes 14
Tokyo 14
Rochester 13
Shanghai 13
Toronto 13
Hangzhou 12
Ipswich 12
Nanjing 12
Piemonte 12
Aarhus 11
Hefei 11
San Mateo 11
Wuhan 10
Casteggio 9
Dallas 9
Munich 9
Ottawa 9
Utrecht 9
Boffalora sopra Ticino 8
Changsha 8
Florence 8
Fossano 8
Hamburg 8
Lincoln 8
London 8
Bogotá 7
Kraainem 7
Kunming 7
Los Angeles 7
Oslo 7
Suri 7
Vaasa 7
Vercelli 7
Alessandria 6
Baltimore 6
Berlin 6
Bologna 6
Falls Church 6
Jinan 6
Lima 6
Novara 6
Redmond 6
Seabrook 6
Bethesda 5
Cassano Magnago 5
Chengdu 5
Genova 5
Leawood 5
Minneapolis 5
Philadelphia 5
Phoenix 5
Trieste 5
Worcester 5
Absecon 4
Arezzo 4
Benton City 4
Blois 4
Catania 4
Chongqing 4
Hyderabad 4
Istanbul 4
Johannesburg 4
Totale 4156
Salva come PNG Salva come JPEG
Nome #
ANALISI DELLA RISPOSTA IMMUNITARIA INNATA IN CHERATINOCITI UMANI DOPO INFEZIONE CON CITOMEGALOVIRUS . 293
Biological relevance of Cytomegalovirus genetic variability in congenitally and postnatally infected children. [*Dell'Oste V, *Landolfo S, co-corresponding authors] 220
The human cytomegalovirus tegument protein pp65 (pUL83): a key player in innate immune evasion 215
The DNA Cytosine Deaminase APOBEC3G is upregulated during Human Cytomegalovirus infection 181
PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas. 178
Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis 172
IL GENE INTERFERON-INDUCIBILE IFI16: POTENZIALE FATTORE ANTIVIRALE E MARCATORE DIAGNOSTICO DELLE INFEZIONI DA PAPILLOMAVIRUS UMANI 170
Regulatory Interaction between the Cellular Restriction Factor IFI16 and Viral pp65 (pUL83) Modulates Viral Gene Expression and IFI16 Protein Stability [*Biolatti M, *Dell'Oste V, co-first authors] 157
The Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING [*Biolatti M, Dell'Oste V* co-first authors] 155
Innate Nuclear Sensor IFI16 Translocates into the Cytoplasm during the Early Stage of In Vitro Human Cytomegalovirus Infection and Is Entrapped in the Egressing Virions during the Late Stage. 152
The human Cytomegalovirus tegument protein pp65 (pUL83) dampens interferon-type I production by inactivating the DNA sensor cGAS 147
NUOVO MECCANISMO DI EVASIONE DEL CITOMEGALOVIRUS UMANO DAL FATTORE DI RESTRIZIONE IFI16. 143
Citrullination during Human Cytomegalovirus infection: implications for autoimmune diseases 142
CHARACTERIZATION OF POST-TRANSLATIONAL MODIFICATIONS DURING HUMAN CYTOMEGALOVIRUS INFECTION: IMPLICATIONS FOR NOVEL ANTIVIRALS 133
Genotypic analysis of HCMV polymorphism in congenital infections to predict the impact of HCMV disease severity in newborns/infants 120
Catch me if you can: the arms race between human cytomegalovirus and the innate immune system [Ganna Galitska*, Matteo Biolatti*, equal contribution) 120
Strigolactones as antiviral drugs to inhibit Herpesvirus replication 117
Regulatory interaction between the cellular restriction factor IFI16 and viral pp65 (pUL83) modulates viral gene expression and IFI16 protein stability 109
Past and ongoing adaptation of human cytomegalovirus to its host. 108
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity. [*Biolatti M, *Dell'Oste V, co-first authors] 107
Strigolactone analogs are promising antiviral agents against Herpesviruses 105
Evasion strategy of Human Cytomegalovirus from the antiviral activities of APOBEC3G 104
A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits. 102
Modulation of the innate immune response by human cytomegalovirus. [*Dell'Oste V., Landolfo S. co-corresponding authors] 100
Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity 100
A Leopard Can Change Its Spots: How HCMV Genetic Variability Impacts Viral Fitness and NK Ligands Immunomodulation 99
HUMAN CYTOMEGALOVIRUS INFECTION TRIGGERS THE INTERFERON RESPONSE VIA THE DNA SENSOR IFI16 IN HUMAN KERATINOCYTES 94
The IFI16 restriction factor cooperates with HCMV pUL83 to down-regulate UL54 gene expression and viral DNA synthesis 93
Metabolic Games: IFI16-Driven Regulation of Cellular Metabolism upon HCMV Infection 92
HPV meets APOBEC: New players in head and neck cancer [*Biolatti M, Dell'Oste V* co-last authors]. 92
A leopard can change its spots: how HCMV genetic variability impacts viral fitness and NK ligands immunomodulation 89
Where do we stand after decades of studying human cytomegalovirus? 89
Early stage IFI16 cytoplasmic translocation and late stage entrapment into egressing virions during HCMV infection 86
COMPARATIVE ANALYSIS OF HUMAN CYTOMEGALOVIRUS CLINICAL ISOLATES FROM KIDNEY TRANSPLANT RECIPIENTS 80
A NOVEL MECHANISM OF HUMAN CYTOMEGALOVIRUS EVASION FROM RESTRICTION FACTOR IFI16. 79
Evasion Strategy of Human Cytomegalovirus to Escape Interferon-β-Induced APOBEC3G Editing Activity 79
HCMV TEGUMENT PROTEINS: NEW INSIGHTS ON INTERACTION BETWEEN THE DNA SENSOR PROTEIN IFI16 AND VIRION PARTICLES 77
Human cytomegalovirus-induced host protein citrullination is crucial for viral replication 75
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection. 74
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity 73
Risk of Symptomatic Infection after Non-Primary Congenital Cytomegalovirus Infection 73
The interferon-inducible DNA-sensor protein IFI16: a key player in the antiviral response 72
Human Cytomegalovirus and Autoimmune Diseases: Where Are We? 71
Regulatory Interaction between the Cellular Restriction Factor IFI16 and Viral pp65 (pUL83) Modulates Viral Gene Expression and IFI16 Protein Stability 70
IFI16 is a Negative Regulator of Glucose and Cellular Lipid Metabolism during Human Cytomegalovirus Infection 70
Tuning the Orchestra: HCMV vs. Innate Immunity. 69
The IFI16 restriction factor cooperates with HCMV pUL83 to down-regulate UL54 gene expression and viral DNA synthesis. 68
The IFI16 restriction factor cooperates with HCMV pUL83 to down-regulate UL54 gene expression and viral DNA synthesis. 65
IFI16 Impacts Metabolic Reprogramming during Human Cytomegalovirus Infection [*Valentina Dell'Oste, *Matteo Biolatti, co-corresponding authors] 65
PAD2 FOR USE IN DIAGNOSING INFECTIONS CAUSED BY VIRUSES OF THE HERPESVIRIDAE FAMILY AND INHIBITORS OR ANTAGONISTS OF PAD2 FOR USE AS ANTI-VIRAL AGENTS AGAINST VIRUSES OF THE HERPESVIRIDAE FAMILY 63
Human Cytomegalovirus pp65 inhibits Interferon type I production through its interaction with the cGAS/STING axis 61
Peptidyl Arginine Deiminases: a Novel Antiviral Target against Human Cytomegalovirus 61
SAMHD1 phosphorylation and cytoplasmic relocalization after human cytomegalovirus infection limits its antiviral activity 57
Synthesis and Biological Evaluation of Amidinourea Derivatives against Herpes Simplex Viruses [*Valentina Dell'Oste, Daniele Castagnolo: co-corresponding authors] 54
Human Cytomegalovirus pp65 inhibits Interferon type I production through its interaction with the cGAS/STING axis 53
Novel antiviral activity of PADs inhibitors against human beta-coronaviruses SARS-CoV-2 and HCoV-OC43 52
NOVEL ANTIVIRAL ACTIVITY OF PADs INHIBITORS AGAINST BETA-CORONAVIRUSES SARS-CoV-2 AND HCoV-OC43 52
PYHIN Proteins and HPV: Role in the Pathogenesis of Head and Neck Squamous Cell Carcinoma 50
Metabolic games: IFI16-driven regulation of cellular metabolism upon HCMV infection 49
STRIGOLACTONES FOR USE IN PREVENTING AND/OR TREATING INFECTIONS CAUSED BY VIRUSES OF THE HERPESVIRIDAE FAMILY 49
Targeting PAD-mediated citrullination to treat human papillomavirus infections 47
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 46
Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ 43
45th International Herpesvirus Workshop 43
Strigolactone analogs are promising antiviral agents for the treatment of human cytomegalovirus infection 42
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection 42
THE GENETIC VARIABILITY OF HUMAN CITOMEGALOVIRUS: POSSIBLE IMPLICATIONS IN CLINICAL, IMMUNOLOGICAL AND VIROLOGICAL SETTINGS 39
Herpes simplex virus type 1 induced citrullination in neuronal cells suggests new therapeutic options for the treatment of virus-associated neurodegenerative disorders 38
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 36
A Leopard Can Change Its Spots: How HCMV Genetic Variability Impacts Viral Fitness and NK Ligands Immunomodulation 35
Targeting PAD-mediated citrullination to treat human papillomavirus infections 31
Strigolactones as broad-spectrum antivirals against β-coronaviruses through targeting SARS-CoV-2 Mpro 30
CONGENITAL CYTOEGALOVIRUS INFECTION: CAN THE DIFFERENCE BETWEEN THE VIRUS’ RELATIONSHIP WITH THE HOST’S IMMUNE SYSTEM EXPLAIN THE DIFFERENCE IN CLINICAL PHENOTYPES? 30
NOVEL ANTIVIRAL ACTIVITY OF PADS INHIBITORS AGAINST HUMAN BETA-CORONAVIRUSES SARS-COV-2 AND HCOV-OC43 27
La variabilità genetica del citomegalovirus umano: possibili implicazioni dal punto di vista clinico, immunologico e virologico 26
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 23
IFI16 IMPACTS METABOLIC REPROGRAMMING DURING HUMAN CYTOMEGALOVIRUS INFECTION 22
50° Congresso Nazionale della Società Italiana di Microbiologia 21
IFI16 Impacts Metabolic Reprogramming During Human Cytomegalovirus Infection 20
Totale 6786
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11453
article - articoli 0
book - libri 0
conference - conferenze 6557
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18010
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018258 0000 00 00 150612126
2018/2019631 26336958 4123 2980 44799851
2019/2020852 182152102 38110 9168 7710471100
2020/20211166 72696658 97118 13275 8415267176
2021/20221294 757191128 7054 6169 4592324214
2022/20232045 13014356279 255537 134212 299000
Totale 6786